Biotech · Private company
CanBas Co. Ltd.
Track this companyFree. Adds CanBas Co. Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- CBP501 (16)Phase 2 · Pancreatic Cancer Stage IVClinicalTrials.gov · fetched Nov 12, 2026
- CBP501 (25)Phase 2 · Pancreatic Cancer Stage IVClinicalTrials.gov · fetched Nov 12, 2026
- CisplatinPhase 2 · Pancreatic Cancer Stage IVClinicalTrials.gov · fetched Nov 12, 2026
- NivolumabPhase 2 · Pancreatic Cancer Stage IVClinicalTrials.gov · fetched Nov 12, 2026
- pemetrexed and cisplatinPhase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- pemetrexed, cisplatin and CBP501Phase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- pemetrexed, cisplatin and CBP501, dose findingPhase 2 · Malignant Pleural MesotheliomaClinicalTrials.gov · fetched Nov 12, 2026
- CBP501Phase 1 · Advanced Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic CancerPHASE2 · COMPLETED · started Dec 18, 2021ClinicalTrials.gov NCT04953962 · fetched Nov 12, 2026
- CBP501, Cisplatin and Nivolumab in Advanced Refractory TumorsPHASE1 · COMPLETED · started Oct 25, 2017ClinicalTrials.gov NCT03113188 · fetched Nov 12, 2026
- Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)PHASE1_PHASE2 · COMPLETED · started May 1, 2008ClinicalTrials.gov NCT00700336 · fetched Nov 12, 2026